| ADMA | Asymmetric dimethylarginine |
| ALT | Alanine transaminase |
| AST | Aspartate aminotransferase |
| AUC | Area under the curve |
| BMI | Body mass index |
| cfDNA | Cell-free deoxyribonucleic acid |
| cGMP | Cyclic guanosine monophosphate |
| CI | Confidence interval |
| DBP | Diastolic blood pressure |
| dsDNA | Double-stranded deoxyribonucleic acid |
| FGR | Fetal growth restriction |
| GA | Gestational age |
| GH | Gestational hypertension |
| HC-FMRP | General Hospital of the Ribeirao Preto Medical School |
| HDP | Hypertensive disorders of pregnancy |
| HELLP | Hemolysis, elevated liver enzymes and low platelet count syndrome; |
| HP | Healthy pregnancy |
| HR | Heart rate |
| LDH | Lactate dehydrogenase |
| MDA-TBARS | Malondialdehyde–thiobarbituric acid reactive substances |
| MMP | Matrix metalloproteinase |
| NG | Normal growth |
| OR | Odds ratio |
| PE | Preeclampsia |
| qPCR | Quantitative real time-polymerase chain reaction |
| ROC | Receiver-operating characteristic |
| rTTM | Responsive to treatment |
| SBP | Systolic blood pressure |
| sEndoglin | Soluble endoglin |
| sFLT | Soluble fms-like tyrosine kinase |
| TIMP | Tissue inhibitor of metalloproteinase |
| TTM | Treatment |